about
Identification of novel VHL target genes and relationship to hypoxic response pathwaysProteomic analysis of increased Parkin expression and its interactants provides evidence for a role in modulation of mitochondrial functionUBE2QL1 is disrupted by a constitutional translocation associated with renal tumor predisposition and is a novel candidate renal tumor suppressor geneAdhesion molecules in inflammatory bowel diseaseInternational network of cancer genome projects.Impact of pre-analytical factors on the proteomic analysis of formalin-fixed paraffin-embedded tissueTumor suppressor activity and epigenetic inactivation of hepatocyte growth factor activator inhibitor type 2/SPINT2 in papillary and clear cell renal cell carcinomaAristolochic acid exposure in Romania and implications for renal cell carcinomaA systematic analysis of the effects of increasing degrees of serum immunodepletion in terms of depth of coverage and other key aspects in top-down and bottom-up proteomic analysesGenome-wide association study of renal cell carcinoma identifies two susceptibility loci on 2p21 and 11q13.3Proteomic profiling of urinary proteins in renal cancer by surface enhanced laser desorption ionization and neural-network analysis: identification of key issues affecting potential clinical utility.Use of laser capture microdissection to selectively obtain distinct populations of cells for proteomic analysis.Clinical proteomics--insights into pathologies and benefits for patients.Laser capture microdissection and two-dimensional polyacrylamide gel electrophoresis: evaluation of tissue preparation and sample limitations.Identification of genes up-regulated in urothelial tumors: the 67-kd laminin receptor and tumor-associated trypsin inhibitor.Analysis of the cytosolic proteome in a cell culture model of familial amyotrophic lateral sclerosis reveals alterations to the proteasome, antioxidant defenses, and nitric oxide synthetic pathways.Proteomic changes in renal cancer and co-ordinate demonstration of both the glycolytic and mitochondrial aspects of the Warburg effect.Phase I trial of intravesical Suramin in recurrent superficial transitional cell bladder carcinomaInfluences of blood sample processing on low-molecular-weight proteome identified by surface-enhanced laser desorption/ionization mass spectrometry.Proteomic profiling using mass spectrometry--does normalising by total ion current potentially mask some biological differences?Integrated multi-level quality control for proteomic profiling studies using mass spectrometry.Using the protein chip interface with quadrupole time-of-flight mass spectrometry to directly identify peaks in SELDI profiles--initial evaluation using low molecular weight serum peaks.Development and validation of a novel protein extraction methodology for quantitation of protein expression in formalin-fixed paraffin-embedded tissues using western blotting.The acute phase protein response in patients receiving subcutaneous IL-6.Measurement of plasma concentrations of polymorphonuclear elastase-alpha 1 proteinase inhibitor (elastase-alpha 1 antitrypsin) in patients with rheumatoid arthritis: interference by rheumatoid factorInitial development and validation of a novel extraction method for quantitative mining of the formalin-fixed, paraffin-embedded tissue proteome for biomarker investigationsGenome-wide association study identifies multiple risk loci for renal cell carcinoma.A pilot study to investigate the potential of mass spectrometry profiling in the discovery of novel serum markers in chronic renal disease.The combination of circulating Ang1 and Tie2 levels predicts progression-free survival advantage in bevacizumab-treated patients with ovarian cancer.Protein Biomarker Research in UK Hospital Clinical Biochemistry Laboratories: A Survey of Current Practice and ViewsAlpha 2 macroglobulin state in acute pancreatitis. Raised values of alpha 2 macroglobulin-protease complexes in severe and mild attacks.Renal cancer biomarkers: the promise of personalized careProteomic analysis of formalin-fixed paraffin-embedded renal tissue samples by label-free MS: assessment of overall technical variability and the impact of block age.Proteomics and the search for biomarkers for renal cancer.Predicting response to bevacizumab in ovarian cancer: a panel of potential biomarkers informing treatment selectionMeasuring carbonic anhydrase IX as a hypoxia biomarker: differences in concentrations in serum and plasma using a commercial enzyme-linked immunosorbent assay due to influences of metal ions.An analysis of the impact of pre-analytical factors on the urine proteome: Sample processing time, temperature, and proteolysis.Proteomic studies in urological malignancies.A genome-wide association study identifies a novel susceptibility locus for renal cell carcinoma on 12p11.23C-STrap Sample Preparation Method--In-Situ Cysteinyl Peptide Capture for Bottom-Up Proteomics Analysis in the STrap Format.
P50
Q24299968-F2E77CB3-60CD-45D2-9EDA-EA233FBD7311Q24312050-289A88E1-FDAF-410C-8809-8329AE275012Q24321830-9E478265-ABFF-43CE-8F01-71DB3BE2DF76Q24541344-529CFA93-C7EA-4D29-86AC-405D521A2558Q24611474-D290BED8-09AC-477B-B2FA-61E2C39ACDF9Q26851269-D001F70A-D549-4D4C-B94C-61B382A5A68DQ28254125-A66D0D80-7CF7-467C-955B-D52A03BD3C79Q28602446-52E6A6A7-1809-4AE6-825E-33D2025EC73CQ28732696-789C23F5-622D-421E-8072-66D47E1C365BQ28943264-E6260E58-4F00-4A8F-AAA1-F4F39A6E0548Q30745340-8EBECD80-D665-43D6-A586-31240195C0EDQ30868541-39AD0865-3A92-4E89-843A-B67E432DF9B0Q30977441-400D2332-4BCA-4BFA-9BE7-FEF9DA8F949BQ31042241-A3CDDE09-8C7D-409B-8CE8-89B809C39A53Q31150349-D102DA8B-6084-4FBB-87C7-4532519A1E2DQ33185412-4E586254-865C-4EDB-8401-5AF4C69B0CCEQ33188191-A23FFEFA-729B-46E8-9E35-20CC4CB8B214Q33216260-2471DA2A-612A-4F48-867D-0B4F04D49420Q33218408-48B0E198-C76C-4679-86C3-AE52C46F5A18Q33311516-F96797A4-7D4D-4903-AFB2-A7A9426AA093Q33389590-4C2C1D15-9163-4BA3-AABB-09BBA217B908Q33399808-369EF1FF-8C2A-4987-9054-7BC0C0C8BAEFQ33401334-1F84FB86-13D3-4E89-B2D0-4BBE94B7B88AQ33488374-B2931DC4-7B0B-46CF-B864-4AFF7222C028Q33562268-CD8FDAED-285F-469C-9493-72491854AB07Q33758692-BFE7A69F-EDFE-4840-BEFB-B54FFDE465B2Q33804470-1A2E2D0F-310D-478F-8AB0-55765C0A9BC1Q33990550-3A2CA404-8567-4E61-B644-3CFE7EBE37C9Q34134697-E3ED2D7D-2291-4BF0-8EDC-FA060E54E570Q34158249-14F89F87-180B-4A0F-8214-D71FD162B9F4Q34394578-BD040EB9-0372-4F4B-8819-2FB96925B554Q34422845-C8C459FB-E635-4D4D-8875-02FAC9583458Q34426108-65B0438A-76A4-4095-A8C1-37F5B212620EQ34508021-E489D0F1-E065-4433-98B4-B1195AC73B72Q34916073-15FA034D-7D21-4248-A3B1-69539A179D11Q35015917-C946838D-47F2-42CF-9241-D6B6C90698ABQ35423674-9050034F-0DE7-4EDD-8829-607423B92FF2Q35598056-27932A3C-FEB5-4A86-AE92-2238DE80B79DQ35747147-9A19F674-1394-48E2-A4DA-A5C3E790C060Q35788434-81620E50-62BE-4177-BF88-B9042D9C78B4
P50
description
hulumtuese
@sq
researcher
@en
researcher
@en-gb
wetenschapper
@nl
հետազոտող
@hy
name
Rosamonde Elizabeth Banks
@ast
Rosamonde Elizabeth Banks
@cy
Rosamonde Elizabeth Banks
@en
Rosamonde Elizabeth Banks
@en-gb
Rosamonde Elizabeth Banks
@es
Rosamonde Elizabeth Banks
@nl
Rosamonde Elizabeth Banks
@sl
type
label
Rosamonde Elizabeth Banks
@ast
Rosamonde Elizabeth Banks
@cy
Rosamonde Elizabeth Banks
@en
Rosamonde Elizabeth Banks
@en-gb
Rosamonde Elizabeth Banks
@es
Rosamonde Elizabeth Banks
@nl
Rosamonde Elizabeth Banks
@sl
altLabel
Rosamonde Banks
@cy
Rosamonde Banks
@en
Rosamonde Banks
@en-gb
prefLabel
Rosamonde Elizabeth Banks
@ast
Rosamonde Elizabeth Banks
@cy
Rosamonde Elizabeth Banks
@en
Rosamonde Elizabeth Banks
@en-gb
Rosamonde Elizabeth Banks
@es
Rosamonde Elizabeth Banks
@nl
Rosamonde Elizabeth Banks
@sl
P106
P21
P2456
P31
P496
0000-0002-0042-8715